Cardiology
Conference Coverage
HRS: Consider ablation for asymptomatic atrial fib
ORLANDO – The Heart Rhythm Society’s revised atrial fibrillation consensus statement said ablation of asymptomatic cases may be considered.
Guidance for Practicing Primary Care
Use of non–vitamin K antagonist oral anticoagulants in the acute care, periprocedural settings
NOACs: Handle with care because only a few have a back door.
From the Journals
Thrombosis risk is elevated with myeloproliferative neoplasms
Diagnosis appears to be the time with greatest risk.
From the Journals
Bariatric surgery comes with some risk of complications
A long-term follow-up study of bariatric surgery patients revealed complication risks.
Conference Coverage
VIDEO: Anticoagulant underprescribing common, jeopardizing atrial fib patients
Drug-prescribing data show many patients with atrial fibrillation are underdosed with anticoagulants, often due to fears about bleeding.
Conference Coverage
Shedding light on shift work’s influence on cardiometabolic risk
LOS ANGELES – Recent findings shed further insight into the link between environmental light, circadian rhythms, and metabolic disorders.
Conference Coverage
VIDEO: Lean body mass linked to atrial fib etiology
ORLANDO – A groundbreaking 2017 Danish study linked new onset atrial fibrillation to higher lean body mass rather than directly to obesity.
From the Journals
Metabolic and bariatric surgery reduces CVD risk in severely obese adolescents
Big losses in BMI can lead to big gains in resolving cardiovascular disease risk in severely obese adolescents.
From the Journals
First month of LABA/LAMA ups cardiovascular risk
Researchers warn physicians to closely monitor new users of LABAs or LAMAs for cardiovascular symptoms.
Commentary
CMS clinical trials raise cardiac mortality
Health agencies should take their cues from randomized clinical trial designs to avoid unintended consequences.
Applied Evidence
Heart failure treatment: Keeping up with best practices
New drugs and devices have emerged for the management of heart failure. Fortunately, there is also clear evidence to guide our decision-making.